- Home
- AI vs FOLD Comparison
AI vs FOLD Comparison
Compare AI & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AI
- FOLD
- Stock Information
- Founded
- AI 2009
- FOLD 2002
- Country
- AI United States
- FOLD United States
- Employees
- AI N/A
- FOLD N/A
- Industry
- AI Computer Software: Prepackaged Software
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- AI Technology
- FOLD Health Care
- Exchange
- AI Nasdaq
- FOLD Nasdaq
- Market Cap
- AI 2.9B
- FOLD 2.9B
- IPO Year
- AI 2020
- FOLD 2007
- Fundamental
- Price
- AI $19.35
- FOLD $6.83
- Analyst Decision
- AI Hold
- FOLD Strong Buy
- Analyst Count
- AI 14
- FOLD 9
- Target Price
- AI $30.15
- FOLD $17.00
- AVG Volume (30 Days)
- AI 3.7M
- FOLD 3.9M
- Earning Date
- AI 05-28-2025
- FOLD 05-08-2025
- Dividend Yield
- AI N/A
- FOLD N/A
- EPS Growth
- AI N/A
- FOLD N/A
- EPS
- AI N/A
- FOLD N/A
- Revenue
- AI $366,923,000.00
- FOLD $528,294,999.00
- Revenue This Year
- AI $28.95
- FOLD $21.83
- Revenue Next Year
- AI $21.94
- FOLD $22.16
- P/E Ratio
- AI N/A
- FOLD N/A
- Revenue Growth
- AI 23.79
- FOLD 32.29
- 52 Week Low
- AI $17.03
- FOLD $6.20
- 52 Week High
- AI $45.08
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- AI 38.45
- FOLD 32.01
- Support Level
- AI $18.97
- FOLD $6.20
- Resistance Level
- AI $21.43
- FOLD $6.95
- Average True Range (ATR)
- AI 1.50
- FOLD 0.43
- MACD
- AI 0.12
- FOLD -0.04
- Stochastic Oscillator
- AI 44.11
- FOLD 29.86
About AI C3.ai Inc.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.